Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II - Related Studies

Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II (TOSS-2)

This study is currently recruiting participants.

Study NCT00130039. Last updated on March 12, 2007. Information provided by Asan Medical Center

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cerebral Infarction
		Atherosclerosis

2	Additional conditions recognized in this trial
		Infarction
		Stroke

3	More general conditions related to this trial
		Arterial Occlusive Diseases
		Arteriosclerosis
		Brain Diseases
		Brain Infarction
		Brain Ischemia
		Cardiovascular Diseases
		Central Nervous System Diseases
		Cerebrovascular Disorders
		Ischemia
		Necrosis
		Nervous System Diseases
		Pathologic Processes
		Vascular Diseases

4	Interventions listed in this trial
		cilostazol versus clopidogrel

5	Additional drug interventions recognized in this trial
		Cilostazol
		Clopidogrel

6	More general drug interventions related to this trial
		Anti-Asthmatic Agents
		Autonomic Agents
		Bronchodilator Agents
		Cardiovascular Agents
		Central Nervous System Agents
		Enzyme Inhibitors
		Fibrin Modulating Agents
		Fibrinolytic Agents
		Hematologic Agents
		Molecular Mechanisms of Pharmacological Action
		Neuroprotective Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Phosphodiesterase Inhibitors
		Physiological Effects of Drugs
		Platelet Aggregation Inhibitors
		Protective Agents
		Respiratory System Agents
		Therapeutic Uses
		Vasodilator Agents

7	Sponsors listed in this trial
		Asan Medical Center
		Korea Otsuka International Asia Arab